Recent discussions on X about TuHURA Biosciences, Inc. (HURA) have centered around a notable stock purchase by a political figure's spouse, sparking curiosity and debate among users. Posts highlight a significant price jump of nearly 87% in the days following the trade, with some questioning the timing and implications of such insider activity. The small market cap and limited employee count of the company have also been points of intrigue, adding fuel to speculative conversations.
Additionally, there is chatter about the company's recent $15.5 million funding round to support a Phase 3 cancer immunotherapy trial, which has drawn attention to its potential in the biotech space. Many on X are closely watching upcoming milestones expected by mid-2025, including a merger completion, as indicators of future performance. The mix of skepticism and optimism keeps the dialogue lively and dynamic.
Note: This discussion summary was generated from an AI condensation of post data.
TuHURA Biosciences, Inc. Congressional Stock Trading
Members of Congress have traded $HURA stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $HURA stock by members of Congress over the last 6 months:
- REPRESENTATIVE LAUREL M. LEE purchased up to $100,000 on 07/13.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
TuHURA Biosciences, Inc. Analyst Ratings
Wall Street analysts have issued reports on $HURA in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 05/16/2025
To track analyst ratings and price targets for TuHURA Biosciences, Inc., check out Quiver Quantitative's $HURA forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
